WHO advises against use of remdesivir for hospitalised COVID-19 patients
Published
Published
Key drug candidate lenzilumab is a recombinant monoclonal antibody Designed to reduce sometimes dangerous side effects associated..
The World Health Organization (WHO) has advised against using Gilead’s remdesivir in patients hospitalized with coronavirus,..